Literature DB >> 18112235

Action of aureomycin against experimental rickettsial and viral infections.

S C WONG, H R COX.   

Abstract

Entities:  

Keywords:  AUREOMYCIN/effects; RICKETTSIAL DISEASES/therapy; VIRUSES/diseases

Mesh:

Substances:

Year:  1948        PMID: 18112235     DOI: 10.1111/j.1749-6632.1948.tb27274.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  Some recent advances and current problems in the field of rickettsial diseases.

Authors:  H R COX
Journal:  Arch Gesamte Virusforsch       Date:  1951

2.  [Aureomycin in experimental psittacosis in the mouse].

Authors:  W SCHMIDT; H VON SPROCKHOFF
Journal:  Z Hyg Infektionskr       Date:  1953

3.  Aureomycin.

Authors:  J CROFTON
Journal:  Postgrad Med J       Date:  1950-07       Impact factor: 2.401

4.  The clinical value of aureomycin; a review of current literature and some unpublished data.

Authors:  L T WRIGHT; H SCHREIBER
Journal:  J Natl Med Assoc       Date:  1949-09       Impact factor: 1.798

5.  [Q-fever in South Baden; diagnosis, clinical aspects and epidemiology of rickettsiasis burnett].

Authors:  H SCHUBOTHE; M BOCK; E WIESMANN
Journal:  Klin Wochenschr       Date:  1951-09-15

6.  Lymphogranuloma venereum; a general review.

Authors:  W E COUTTS
Journal:  Bull World Health Organ       Date:  1950       Impact factor: 9.408

7.  Viral Infections of the Human Nervous System: Classification and General Considerations.

Authors:  A B Sabin
Journal:  Postgrad Med J       Date:  1950-03       Impact factor: 2.401

8.  A new member of the psittacosis-lymphogranuloma group of viruses that causes infection in calves.

Authors:  C J YORK; J A BAKER
Journal:  J Exp Med       Date:  1951-06       Impact factor: 14.307

9.  Studies on the psittacosislymphogranuloma group. III. The effect of aureomycin on the propagation of virus in the chick embryo.

Authors:  E G ALLEN; A J GIRARDI; M M SIGEL; M KLEIN
Journal:  J Exp Med       Date:  1953-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.